Repository: UIHistories Project: Board of Trustees Minutes - 1982 [PAGE 188]

EXTRACTED TEXT FROM PAGE:

1981]

UNIVERSITY OF ILLINOIS

177

On January 29, 1981, the inventors met with the University Patent Committee, seeking an adjustment in the light of their special circumstances. T h e inventors noted that, in addition to originating the discovery, they had expended considerable amounts of time, money, and effort to improve the commercial feasibility of the device and to bring about commercial interest which resulted in the license proposals acted upon by the foundation. The inventors requested that, based on these unique circumstances, the patent committee recommend an increase in the royalty income distribution share that inventors generally receive. The University Patent Committee now has recommended that, in lieu of the general formula, the inventors receive the first $100,000 of net income, after expenses, received by the University or the foundation on this invention ($5,000 has been received to date), plus 20 percent of all such net income in excess of $100,000. I concur. O n m o t i o n of M r . H a h n , this r e c o m m e n d a t i o n w a s a p p r o v e d .

Agreement with Institut Merieux Research (Exception to General Rules)

(11) Vaccines for certain diseases have been developed by Drs. Miodrag Ristic and Michael G. Levy of the College of Veterinary Medicine at Urbana-Champaign. University Patents, Inc., has entered into an agreement with International Minerals and Chemical Corporation for the development of a soluble antigen vaccine for babesiosis, a significant disease of cattle, horses, and dogs and, rarely, humans. Other diseases in the babesiosis group include leismaniaisis, trypanosomiasis, and malaria. International Minerals and Chemical has negotiated for and received a right of first review of any developments made by Professors Ristic and Levy in the malaria field and expects to relinquish this right to the Institut Merieux, Lyon, France, which believes that the invention may well solve the problem of providing effective protection against these diseases and wishes to support work leading to further development of the vaccines. Institut Mirieux now has presented an agreement for cooperative research to the University of Illinois for execution and a part of this agreement deviates from the General Rules concerning patent provisions. T h e University Patent Committee has reviewed the proposed agreement and recommends that the Board of Trustees approve its acceptance, with the following language as an exception to the General Rules: Any inventions or developments resulting from the work provided for hereunder shall be transferred by the University of Illinois to the University of Illinois Foundation, provided, however, that any inventions or developments made jointly by the inventors and the sponsor will be jointly owned by the University and the sponsor. I concur.

On motion of Mr. Hahn, this recommendation was approved. Recommendations of the University Patent Committee

(12) T h e University Patent Committee has submitted the following recommendations relating to discoveries and developments by staff members. Background material concerning these recommendations has been sent to the Committee on Patents of the Board of Trustees. 1. Polymeric Device — Alan H . Brightman, assistant professor of veterinary clinical medicine, and Michael C. Theodorakis, assistant professor of veterinary biosciences and in the Center for Zoonoses Research in the College of Veterinary Medicine and assistant professor of bioengineering in the College of Engineering, Urbana-Champaign, inventors.